Number of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI
|
|
- Elfreda Phelps
- 5 years ago
- Views:
Transcription
1 Clinical Approach to the Patient t with Dyspepsia William D. Chey, MD, FACG Professor of Medicine University of Michigan Prevalence of Endoscopic Findings in Individuals with Dyspepsia Systematic Review and Meta-analysis analysis including 9 studies Endoscopic finding Number of studies Number of subjects Pooled prevalence 95% CI Erosive esophagitis % Barrett s esophagus % Peptic ulcer % Gastric ulcer % Duodenal ulcer % Gastric cancer % Esophageal cancer % Ford, et al. Clin Gastroenterol Hepatol 2010;8:830 1
2 Rome III: Diagnostic Criteria* for Functional Dyspepsia Must include 1. One or more of: a. Bothersome postprandial fullness b. Early satiation c. Epigastric pain d. Epigastric burning AND 2. No evidence of structural disease (including at upper endoscopy) that is likely to explain the symptoms *Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis Tack, et al. Gastroenterol 2006;130:1466 Functional Dyspepsia: Rome III Subgroups PDS EPS Postprandial Distress Syndrome Postprandial fullness Early satiation Epigastric pain Syndrome Intermittent epigastric pain/burning Tack, et al. Gastroenterol 2006;130:1466 2
3 Clinical Impact of Dyspeptic Symptoms in the General Population Proportion Affected (%) Wgt loss Absenteeism 2025 Belgians 21% had significant dyspepsia 34% had co-morbid GERD symptoms Piessevaux et al. Neurogastro Motil 2009;21:378 Affected Daily Life Led to Healthcare Util Meds Pathogenesis of Functional Dyspepsia Altered Brain-Gut Interactions Genetic Factors Visceral Hypersensitivity y Functional Dyspepsia Microbiome Inflammation Post-infectious Abnormal upper GI motor & reflex functions Psychosocial Factors Saad & Chey. Aliment Pharmacol Ther 2006;24:475 3
4 Current Management of Functional Dyspepsia H. pylori eradication Prokinetic Antisecretory t therapy therapy Current Management of Functional Dyspepsia Diet Lifestyle CAM H. pylori eradication Anti- Nociceptive Prokinetic Antisecretory t therapy therapy 4
5 Dietary Recommendations for Functional Dyspepsia: What s the Evidence? Efficacy of dietary interventions has not been carefully studied in Functional Dyspepsia Smaller meals may better tolerated - Patients develop fullness and other symptoms with smaller volumes of a nutrient drink or water vs. controls - FD symptoms directly related to overall calorie intake Avoid high fat meals - Ingestion of fat or intraduodenal lipid infusion leads to more symptoms in patients vs. controls - Fat but not carbohydrate intake directly related to symptoms Feinle-Bisset, Neurogastroenterol Motil 2006; 18:608 Pilichiewicz, Clin Gastroenterol Hepatol 2009;317 Cochrane Meta-Analysis of H. pylori Cure for Functional Dyspepsia 17 RCTs (3566 patients) Hp eradication therapy vs. placebo or short course of PPI % Symptom Therapeutic Improvement Gain (%) (range) NNT RRR (95% CI) (%) Hp cure 36 (15-75) (10-25) (6-14) Placebo 29 (7-51) 12/17 trials did not show significant benefits with Hp eradication Moayyedi et al. Cochrane Collaboration Feb
6 The Rationale for Antisecretory Therapy in Functional Dyspepsia Gastric acid secretion in FD similar to controls 1 Acid hypersensitivity - Lowered threshold of mechanosensitive afferents 2, reduced antral motility, jejunal hypercontractions 3 - Increased symptoms with duodenal acid infusion 3, 4 Increased duodenal acid exposure Decreased fasting clearance of exogenous acid - Decreased fasting duodenal motor activity Overlap of GERD and dyspeptic symptoms 7 1 Bechi et al. Dig Dis Sci 1992; 37:378 4 Sansom et al. Gastroenterol 1999; 116:515 2 Coffin et al. Am J Physiol 2001; 280:G904 5 Lee et al. Am J Gastro 2004; 99: DiStefano et al. Neurogastro Motil 2009;21:712 6 Ishii et al. J Sm Muscle Res 2010;46:1 7 Tack et al. Gut 2005; 54:1370 Cochrane Meta-Analysis of PPI therapy for Functional Dyspepsia 10 RCTs (3347 patients) PPI for 2-8 weeks was superior to placebo in relieving FD symptoms % No or Therapeutic minimal Gain NNT RRR (%) symptoms (%) (95% CI) (95% CI) PPI (7-33) (4-20) Placebo 25 No assymetry by funnel plot Moayyedi et al. Cochrane Collaboration
7 PPI for Functional Dyspepsia: Is a 1 week trial adequate? Properties at 8 weeks according to treatment response in week 1 Week 8 Sensitivity Specificity PPV NPV (95% CI) (95% CI) (95% CI) (95% CI) Eso or 80 mg (41-52) (76-84) (54-67) (65-73) Placebo (22-44) (81-93) (45-76) (61-76) N = 1150 Eso 40 mg QD or BID Europe, South America, Canada, Singapore Bottom Line One week of PPI therapy did not reliably identify responders at 8 weeks Talley et al. Aliment Pharmacol Ther 2007;26:673 Which factors predict response to PPI therapy in FD? Patients with reflux symptoms more likely to respond to PPI therapy 1 Patients with dysmotility symptoms are less likely to improve with PPI therapy 1 - Case control studies suggest nausea 2 and bloating/ibs symptoms 3,4 are negative predictors of PPI response 1 Talley APT 1998;12: Meineche-Schmidt Am J Gastro 2000;95: Bolling-Sternevald Aliment Pharmacol Ther 2003;18:117 4 Meineche-Schmidt Aliment Pharmacol Ther 2011;33:41 7
8 How does abnormal gastric physiology contribute to Upper GI Symptoms? Dyspeptic symptoms and meal-related pathophysiologic mechanisms 23% Delayed gastric emptying nausea, vomiting, and post-prandial prandial fullness 35% Hypersensitivity to gastric distension pain, belching, and weight loss 40% Impaired accommodation early satiety, and weight loss Tack et al, Gastroenterology 2004; 127:
9 Types of prokinetics Metoclopramide Domperidone Cisapride Erythromycin y Itopride Tegaserod ABT-229 Dopamine-2 antagonist HT 4 agonist HT 3 antagonist Motilin receptor agonist + ++ Cholinesterase inhibitor ++ QT prolongation Cochrane Meta-Analysis of Prokinetics for Functional Dyspepsia 19 RCTs (3178 patients) % No or Therapeutic minimal Gain NNT RRR (%) symptoms (%) (95% CI) (95% CI) Prokinetics (5-12) (18-45) Placebo 47 Significant assymetry by funnel plot Moayyedi et al. Cochrane Collaboration
10 Domperidone for Functional Dyspepsia 9 double-blind studies (30-60 mg/day) - Peripheral dopaminergic antagonist Reduced CNS side effects - Improvement in global assessment without clear effects on gastric emptying - Increases serum prolactin levels Breast tenderness and galactorrhea in <5% - Can prolong QT interval - Not currently available in the US - IND program available Van Zanten Am J Gastroenterol 2001; 96: 689 Reddymasu,et al. Am J Gastroenterol 2007;102:1 Camilleri et al. Am J Gastroenterol 2013;108:18 Responder Rates with Acotiamide for Functional Dyspepsia * * * *P<.05 compared with placebo EPS: Epigastric pain syndrome; GSOA: Global subject outcome assessment; PDS: Postprandial distress syndrome; t.i.d.: Three-times a day Altan E, et al. Expert Rev Gastroenterol Hepatol 2012;6:533 10
11 Effect of Buspirone or Placebo on Dyspepsia Symptom Severity *P<.05 Randomized, double-blind, placebo-controlled, crossover study: Buspirone (n=7) 10 mg or placebo (n=10) tid before meals x 4 weeks Tack J, et al. Clin Gastroenterol Hepatol 2012;10:1239 Effect of Buspirone or Placebo on Individual Meal-Related Symptom Severity * ** * *P<.05 vs. run-in **P<.005 vs. baseline P<.05 vs. placebo Randomized, double-blind, placebo-controlled, crossover study: Buspirone (n=7) 10 mg or placebo (n=10) tid before meals x 4 weeks Tack J, et al. Clin Gastroenterol Hepatol 2012;10:
12 Psychopharmacological Therapies for Functional Dyspepsia Venlafaxine for Functional Dyspepsia: Double-blind, Placebo-Controlled Trial 50 In a multicenter trial of 160 FD pts, venlafaxine was no more effective than placebo %IT TT Responders Venlafaxine Placebo 0 Baseline Weeks On treatment Van Kerkhoven, et al. Clin Gastroenterol Hepatol 2008;6:746 12
13 A randomized, controlled trial of Sertraline for Functional Dyspepsia *P=0.124 *P=0.740 N=98 N=95 Rome Ⅱ FD Sertraline 50 mg or Placebo daily for 8 wk 22% dropped out No difference in QoL or HAD scores Tan YPY, et al. World J Gastroenterol 2012;18:6131 The Functional Dyspepsia treatment trial: Key Results % Primary Endpoint: Adequate Relief (%)* 5/12 weeks of adequate relief p = % 40% 38% Placebo N = 97 Amitriptyline 50 mg N = 97 Escitalopram 10 mg N = 98 Patients with ulcer-like but not dysmotility-like improved with amitriptyline Locke et al. DDW 13, abs
14 Take Home Points: Functional dyspepsia and antidepressants Amitriptyline, but not Escitalopram, was efficacious for the global symptoms of functional dyspepsia Treatment effect of amitriptyline was greatest in the ulcer-like FD subgroup and in males Response was not predicted by patient characteristics (e.g., anxiety, BMI) or baseline GI physiology test results Locke et al. DDW 13, abs 810 Treatment of Functional Dyspepsia Epigastric Pain Antidepressant or behavioral therapy + Severe Test and treat Hp Moderate and/or empiric PPI + Mild Positive diagnosis Diet, lifestyle advice Reassure, OTC treatments Physician-patient relationship Complimentary Therapies? 14
15 Treatment of Functional Dyspepsia Epigastric Pain Test and treat Hp and/or Empiric PPI Antidepressant or behavioral therapies? Severe Moderate Post-prandial distress + + Fundus Relaxing Agents Prokinetics Anti-emetics + Positive diagnosis Positive diagnosis Diet, lifestyle advice Mild Diet, lifestyle advice Reassure, OTC Reassure, OTC treatments treatments Physician-patient relationship Physician-patient relationship Complimentary Therapies? + 15
Functional Dyspepsia
Functional Dyspepsia American College of Gastroenterology Boston Massachusetts, June 2015 Brian E. Lacy, PhD, MD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology
More informationManagement of Functional Dyspepsia (FD)
Management of Functional Dyspepsia (FD) Amy S. Oxentenko, MD, FACG Program Director and Associate Chair, IM Associate Professor of Medicine Mayo Clinic, Rochester Outline Define functional dyspepsia (FD)
More informationFunctional Heartburn and Dyspepsia
Functional Heartburn and Dyspepsia Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Objectives Understand the means of diagnosing functional heartburn
More informationThe PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures
The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia Lana Bistritz MD FRCPC Royal Alexandra Hospital GI Update 2016 Disclosures I have no relevant financial disclosures I will be discussing off
More informationOutline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments
Chronic Dyspepsia Eamonn M M Quigley MD FRCP FACP MACG FRCPI Lynda K and David M Underwood Center for Digestive Disorders Houston Methodist Hospital Houston, Texas Outline Definition (s) Epidemiology Pathophysiology
More informationGrigoris Leontiadis, MD PhD. McMaster University Upper Gastrointestinal and Pancreatic Diseases Cochrane Group
Grigoris Leontiadis, MD PhD McMaster University Upper Gastrointestinal and Pancreatic Diseases Cochrane Group No relevant financial relationships with any commercial interests CDDW/CASL Meeting Session:
More informationDefinition, Pathogenesis, and Management of That Cursed Dyspepsia
Clinical Gastroenterology and Hepatology 2018;16:467 479 Definition, Pathogenesis, and Management of That Cursed Dyspepsia Pramoda Koduru, Malcolm Irani, and Eamonn M. M. Quigley IM F1 김영기 Dyspepsia Umbrella
More informationNon-Ulcer Dyspepsia: what is it? What can we do with these patients? Overview. Dyspepsia Definition. Functional Dyspepsia. Dyspepsia the Basics
Non-Ulcer : what is it? What can we do with these patients? Temporal Changes and Geographic Variations in Developing Peptic Ulcer Disease Gastric Cancer 1900 Eamonn M M Quigley MD FACG Alimentary Pharmabiotic
More information6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other
Peptic Ulcer Disease and Dyspepsia John M. Inadomi, MD Professor of Medicine UCSF Chief, Clinical Gastroenterology San Francisco General Hospital Case History 49 y/o woman complains of several months of
More informationCHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal
More informationA Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori- Negative Primary Care Patients with Dyspepsia in Japan
Gut and Liver, Vol. 7, No. 1, January 2013, pp. 16-22 ORiginal Article A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori- Negative Primary Care Patients with Dyspepsia in Japan Tomoari
More informationJune By: Reza Gholami
ACG/CAG guideline on Management of Dyspepsia June 2017 By: Reza Gholami DEFINITION OF DYSPEPSIA AND SCOPE OF THE GUIDELINE Dyspepsia was originally defined as any symptoms referable to the upper gastrointestinal
More informationReal World Efficacy and Tolerability of Acotiamide in Relieving Multiple and Overlapping Symptoms in Patients of Functional Dyspepsia
Archives of Gastroenterology and Hepatology Volume 1, Issue 1, 2018, PP: 1-6 Real World Efficacy and Tolerability of Acotiamide in Relieving Multiple and Overlapping Symptoms in Varsha Narayanan 1 *, Shailesh
More informationNew Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome
New Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome Soojong Hong Chae, MD Clinical Assistant Professor Digestive Diseases and Nutrition University of South Florida ROME III Functional dyspepsia
More informationDyspepsia: alarm symptoms, investigation and management
Drug review Dyspepsia Dyspepsia: alarm symptoms, investigation and management SPL Steven Fong MRCP and Jason Dunn PhD, MRCP Dyspepsia is a common symptom and the priority is to identify alarm signals that
More informationGASTROPARESIS. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis
GASTROPARESIS C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis Symptom Definitions Nausea: a subjective feeling of wanting to vomit Vomiting: forceful expulsion of gastroduodenal
More informationDyspepsia is a problem commonly seen by primary
Concise Review for Clinicians Nonulcer Dyspepsia: What It Is and What It Is Not G. RICHARD LOCKE III, MD Nonulcer dyspepsiais a description of persistent or recurrent upper abdominal pain or discomfort
More informationChapter 1. General introduction and outline
Chapter 1 General introduction and outline General introduction The function of the stomach comprises storage of ingested food, production of gastric secretion and mixing food with gastric secretion,
More informationThe Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease
Gut and Liver, Vol. 8, No. 2, March 2014, pp. 160-164 ORiginal Article The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal
More informationDisclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome
Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium
More informationFunctional Dyspepsia, Delayed Gastric Emptying and Impaired Quality of Life
Gut Online First, published on December 1, 2005 as 10.1136/gut.2005.078634 Functional Dyspepsia, Delayed Gastric Emptying and Impaired Quality of Life NJ Talley 1, GR Locke III 1, BD Lahr 2, AR Zinsmeister
More informationTreating H. pylori in 2016
Treating H. pylori in 2016 William D. Chey, MD, FACG Professor of Medicine University of Michigan The Case: A 38 yo Russian man presents with recurrent epigastric pain which occurs after meals and sometimes
More informationGastrointestinal motility modulating drugs include all compounds which have pharmacological
Pharmacotherapeutics Gastrointestinal Motility Modulating Drugs Oh Young Lee, MD Department of Internal Medicine, Hanyang University College of Medicine E - mail : leeoy@hanyang.ac.kr J Korean Med Assoc
More informationProton-pump inhibitors for the treatment of functional dyspepsia
Therapeutic Advances in Gastroenterology Review Proton-pump inhibitors for the treatment of functional dyspepsia Hidekazu Suzuki, Sawako Okada and Toshifumi Hibi Ther Adv Gastroenterol (2011) 4(4) 219
More informationIBS: overview and assessment of pain outcomes and implications for inclusion criteria
IBS: overview and assessment of pain outcomes and implications for inclusion criteria William D. Chey, MD Professor of Medicine University of Michigan What is the Irritable Bowel Syndrome Symptom based
More informationCAM & Common GI Complaints: Objectives
Complementary and Alternative Medicines (CAM) for Common GI Complaints Brian E. Lacy, Ph.D., M.D., FACG Professor of Medicine i Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology
More informationDOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the
DOMPERIDONE BNF 4.6 Class: Prokinetic anti-emetic. Indications: Nausea and vomiting, dysmotility dyspepsia, gastro-oesophageal reflux. Pharmacology Domperidone is a dopamine type 2-receptor antagonist.
More informationFunctional Dyspepsia
Linköping University Medical Dissertations No. 792 Functional Dyspepsia Symptoms and Response to Omeprazole in the Short Term by Elisabeth Bolling-Sternevald Department of Biomedicine and Surgery, Faculty
More informationMANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES
Enrique Rey Professor of Medicine Head. Department of Digestive Diseases Hospital Clínico San Carlos Complutense University Madrid, Spain MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES CONSTIPATION:
More information11/19/2012. Comparison between PPIs G CELL. Risk ratio (95% CI) Patient subgroup. gastrin. S-form of omeprazole. Acid sensitive. coated.
REGULATION OF GASTRIC ACID SECRETION Comparison between PPIs Omeprazole Lansoprazole Rabeprazole Pantoprazole Esomeprazole gastrin G CELL + Acid sensitive Yes T1/2 30-60 minutes Main elimination Enteric
More informationUnmet Needs in the Management of Gastroesophageal Reflux Disease
Unmet Needs in the Management of Gastroesophageal Reflux Disease Ronnie Fass MD Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal
More informationSUPPLEMENTARY INFORMATION Associated with
Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS
More informationUpdates in Evaluation and Management of Dyspepsia and H. Pylori Infection
Updates in Evaluation and Management of Dyspepsia and H. Pylori Infection Isabel Lee, MD Associate Professor of Health Sciences UCSF Department of Family and Community Medicine Disclosures None 2 Session
More informationFUNCTIONAL DISORDERS TREATMENT ADVANCES. Dr. Adriana Lazarescu MD FRCPC Director GI Motility Lab, Edmonton Associate Professor University of Alberta
FUNCTIONAL DISORDERS TREATMENT ADVANCES Dr. Adriana Lazarescu MD FRCPC Director GI Motility Lab, Edmonton Associate Professor University of Alberta Name: Dr. Adriana Lazarescu Conflict of Interest Disclosure
More informationCigarette Smoking and its Association with Overlapping Gastroesophageal Reflux Disease, Functional Dyspepsia, or Irritable Bowel Syndrome
ORIGINAL ARTICLE Cigarette Smoking and its Association with Overlapping Gastroesophageal Reflux Disease, Functional Dyspepsia, or Irritable Bowel Syndrome Yasuhiro Fujiwara, Makiko Kubo, Yukie Kohata,
More informationBurning Issues in Gastroesophageal Reflux Disease (GERD)
3:45 4:45pm Burning Issues in GERD SPEAKER Prateek Sharma, MD, FACG, FACP Presenter Disclosure Information The following relationships exist related to this presentation: Prateek Sharma, MD, FACG, FACP,
More informationThe long-term impact of the low-fodmap diet for management of irritable bowel syndrome. Dr Miranda Lomer RD.
The long-term impact of the low-fodmap diet for management of irritable bowel syndrome Dr Miranda Lomer RD Email: miranda.lomer@kcl.ac.uk What is IBS - ROME IV Criteria A functional bowel disorder in which
More informationMANAGEMENT OF DYSPEPSIA
Review Article MANAGEMENT OF DYSPEPSIA Raeefuddin Ahmed* SUMMARY Upper gastro-intestinal motility disorders are not uncommon. While the exact prevalence in Pakistan is not known there are substantial number
More informationHold the Wrap! There is so much more to be done!
Hold the Wrap! There is so much more to be done! (Well, a few things that can be done.) (Well, not all that much, really ) (But Blair has never killed anyone with a PPI!) Nicholas Shaheen, MD, MPH Center
More informationDyspepsia is a constellation of symptoms referable to the gastroduodenal
Review Article Dan L. Longo, M.D., Editor Functional Dyspepsia Nicholas J. Talley, M.D., and Alexander C. Ford, M.D. Dyspepsia is a constellation of symptoms referable to the gastroduodenal region of the
More informationFunctional Dyspepsia. Norbert Welkovics Heine van der Walt
Norbert Welkovics Heine van der Walt Characteristics: Central abdomen Pain or discomfort Not associated with bowel movements No structural or biochemical abnormalty Definition Part of Gastroduodenal disorders
More informationDoes the Injection of Botulinum Toxin Improve Symptoms in Patients With Gastroparesis?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2014 Does the Injection of Botulinum Toxin
More informationDisclosures. Proton Pump Inhibitors Deprescribing? Deprescribing PPI Objectives. Deprescribing. Proton Pump Inhibitors (PPI) 5/28/2018.
Proton Pump Inhibitors Deprescribing? None Disclosures Chad Burski, MD Assistant Professor of Medicine UAB Gastroenterology Deprescribing PPI Objectives AR Why? Who? How? The mechanism of action of Proton
More informationEamonn M.M. Quigley, John Keohane, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland
Authors and Disclosures www.medscape.com Eamonn M.M. Quigley, John Keohane, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland From Current Opinion in Gastroenterology Dyspepsia Eamonn
More informationJNM Journal of Neurogastroenterology and Motility
ㅋ JNM Journal of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 18 No. 2 April, 2012 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm.2012.18.2.150 Special Article Asian
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation
More informationRefractory GERD : case presentation and discussion
Refractory GERD : case presentation and discussion Ping-Huei Tseng National Taiwan University Hospital May 19, 2018 How effective is PPI based on EGD? With GERD symptom 75% erosive 25% NERD Endoscopy 81%
More informationPharmacotherapy for IBS
Pharmacotherapy for IBS Brooks D. Cash, M.D., FACG Chief, Gastroenterology Professor of Medicine University of South Alabama Director, GI Physiology, USA Medical Center Mobile, AL Disclosures I have served
More informationF unctional gastrointestinal disorders (FGID) are clinical
1445 IRRITABLE BOWEL SYNDROME Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters
More informationA placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
Gut Online First, published on December 9, 2011 as 10.1136/gutjnl-2011-301454 Gastroduodenal 1 Sakura Life Clinic, Tokyo, Japan 2 Department of Comprehensive Medicine, Tohoku University Hospital, Sendai,
More informationDyspepsia and upper gastrointestinal bleeding. Dr. Wayne H.C. Hu 胡興正
Dyspepsia and upper gastrointestinal bleeding Dr. Wayne H.C. Hu 胡興正 25 year old medical student Occasional smoker and drinker. About to take final examinations. 3 week history of epigastric bloating. Worse
More informationAn approach to dyspepsia for the pharmacist
An approach to dyspepsia for the pharmacist Ilse Truter, DCom, BPharm, MSc, PhD, Drug Utilization Research Unit (DURU) Department of Pharmacy, Nelson Mandela Metropolitan University Correspondence to:
More informationApproach to Patients with Non-Cardiac Chest Pain
Approach to Patients with Non-Cardiac Chest Pain Ronnie Fass, MD Professor of Medicine Case Western Reserve University Definition Noncardiac chest pain is defined as recurrent chest pain that is indistinguishable
More informationQUICK QUERIES. Topical Questions, Sound Answers
QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University
More informationMotility Conference Ghrelin
Motility Conference Ghrelin Emori Bizer, M.D. Division of Gastroenterology/Hepatology November 21, 2007 Ghrelin: Basics Hormone produced by the A-like A endocrine cells in the oxyntic mucosa (stomach body
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationGastroparesis. - Recent advances in the pathophysiology and treatment -
ICDM 2015 Gastroparesis - Recent advances in the pathophysiology and treatment - Department of Internal Medicine, College of Medicine, St. Paul s hospital, The Catholic University of Korea, Seoul, Korea
More informationFEATURE ARTICLE DYSPEPSIA MANAGEMENT IN A RESOURCE POOR SETTING
FEATURE ARTICLE DYSPEPSIA MANAGEMENT IN A RESOURCE POOR SETTING A.C. Jemilohun 1 and J.O. Fadare 2 Ann Ibd. Pg. Med 2013. Vol.11, No.1 2-6 1. Department of Medicine, Ladoke Akintola University of Technology,
More informationMaastricht Ⅴ /Florence
2016 21 10 577 Maastricht Ⅴ /Florence 200001 2015 10 8 9 Maastricht V 1 / 2 3 4 / 5 Maastricht Ⅴ Interpretation of Management of Helicobacter pylori Infection the Maastricht Ⅴ / Florence Consensus Report
More informationORIGINAL ARTICLE. Abstract. Introduction. Masaki Miyamoto 1, Noriaki Manabe 2 and Ken Haruma 2
ORIGINAL ARTICLE Efficacy of the Addition of Prokinetics for Proton Pump Inhibitor (PPI) Resistant Non-erosive Reflux Disease (NERD) Patients: Significance of Frequency Scale for the Symptom of GERD (FSSG)
More informationMANAGEMENT OF VISCERAL PAIN
MANAGEMENT OF VISCERAL PAIN William D. Chey, MD, FACG Professor of Medicine University of Michigan 52 year old female with abdominal pain 5 year history of persistent right sided burning/sharp abdominal
More informationF unctional dyspepsia and gastro-oesophageal reflux disease
1370 GORD Prevalence of acid reflux in functional dyspepsia and its association with symptom profile J Tack, P Caenepeel, J Arts, K-J Lee, D Sifrim, J Janssens... See end of article for authors affiliations...
More informationpissn: eissn: Journal of Neurogastroenterology and Motility
JNM J Neurogastroenterol Motil, Vol. 20 No. 3 July, 2014 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm14022 Original Article Effects of Chili Treatment on Gastrointestinal and Rectal
More informationACG and CAG Clinical Guideline: Management of Dyspepsia
988 CLINICAL GUIDELINES CME ACG and CAG Clinical Guideline: Management of Dyspepsia Paul M. Moayyedi, MB, ChB, PhD, MPH, FACG 1, Brian E. Lacy, MD, PhD, FACG 2, Christopher N. Andrews, MD 3, Robert A.
More informationAppropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist
Appropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist Disclosures I have no actual or potential conflicts of interest to report in relation to this
More informationDavid Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:
David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical
More informationPREVALENCE OF ACID REFLUX IN FUNCTIONAL DYSPEPSIA AND ITS ASSOCIATION WITH SYMPTOM PROFILE
Gut Online First, published on June 21, 2005 as 10.1136/gut.2004.053355 1 Short title: PREVALENCE OF ACID REFLUX IN FUNCTIONAL DYSPEPSIA AND ITS ASSOCIATION WITH SYMPTOM PROFILE ph monitoring in functional
More informationGastroptosis is Associated with Less Dyspepsia, Rather than a Cause of Dyspepsia, in Japanese Persons
ORIGINAL ARTICLE Gastroptosis is Associated with Less Dyspepsia, Rather than a Cause of Dyspepsia, in Japanese Persons Motoyasu Kusano 1, Fumitaka Moki 2, Hiroko Hosaka 2, Yasuyuki Shimoyama 1, Osamu Kawamura
More informationFDA s GREAT Workshop. Industry Perspective: Development Activities Towards Phase 3 Endpoints. September 19, 2012
FDA s GREAT Workshop Industry Perspective: Development Activities Towards Phase 3 Endpoints Malcolm Hill, Pharm.D. Meritage Pharma, Inc. San Diego, CA 09/19/12 1 September 19, 2012 Presentation Overview
More informationSubgroups of Dyspepsia
Chapter 2 Subgroups of Dyspepsia Bojan Tepeš Keywords: Dyspepsia, Organic dyspepsia, Functional dyspepsia, Diagnostic criteria, Postprandial distress syndrome, Epigastric pain syndrome Introduction Dyspepsia
More informationFamotidine Extended Abstracts
Famotidine Extended Abstracts I) Primary literature Summary Ciccone, Decktor, et. al. Efficacy and tolerability of famotidine in preventing heartburn and related symptoms of upper gastrointestinal discomfort.
More informationGERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University
GERD: 2014 Dilemmas and Solutions Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University How to Maximize Your PPI Treatment? Improve compliance and adherance Fass R. Am J Gastroenterol.
More informationGastrointestinal symptoms are still common in a general Western population
ORIGINAL ARTICLE Gastrointestinal are still common in a general Western population L.A.S. van Kerkhoven *, T. Eikendal, R.J.F. Laheij, M.G.H. van Oijen, J.B.M.J. Jansen Department of Gastroenterology &
More informationDisorders in which symptoms cannot be explained by the presence of structural or tissue abnormalities Irritable bowel syndrome Functional heartburn Functional dyspepsia Functional constipation Functional
More informationNEGATIVE ENDOSCOPY, What is the Diagnosis and Treatment?
NEGATIVE ENDOSCOPY, PPI REFRACTORY REFLUX: What is the Diagnosis and Treatment? Michael F. Vaezi, MD, PhD, MSc, FACG Professor of Medicine Clinical Director Division of Gastroenterology, Hepatology and
More informationCurrent status of functional dyspepsia in Korea
REVIEW Korean J Intern Med 2014;29:156-165 Current status of functional dyspepsia in Korea Hyuk Lee 1, Hye-Kyung Jung 2, Kyu Chan Huh 3, and Functional Dyspepsia Study Group in the Korean Society of Neurogastroenterology
More informationThe speed of eating and functional dyspepsia
Original Article * CABM, FRCP, FACP MD JFac Med Baghdad 2016; Vol.58, No.4 Receive June. 2016 Accepted Nov..2016 Introduction: Abstract: Background: dyspepsia is a common complaint, affecting about 26-41%
More informationOmeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod
Aliment Pharmacol Ther 2005; 22: 59 65. doi: 10.1111/j.1365-2036.2005.02528.x Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod G. TOUGAS*,,D.L.EARNESTà, Y. CHEN*,
More informationTitle. CitationDigestion, 87(1): Issue Date Doc URL. Rights. Type. File Information. Novel Drinking-Ultrasonography Test
Title Comparison of Gastric Relaxation and Sensory Functio Novel Drinking-Ultrasonography Test Hata, Tamotsu; Kato, Mototsugu; Kudo, Takahiko; Nish Author(s) Hirota, Jyojyo; Kamada, Go; Ono, Shouko; Nakagawa,
More informationRumination Definition
Ronnie Fass MD, FACG Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal and Swallowing Center MetroHealth Medical Center Cleveland,
More informationFinal published version:
Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome Shadi S. Yarandi, Emory University
More informationUrea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013
MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index
More informationGERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018
GERD DIAGNOSIS & TREATMENT Subhash Chandra MBBS Assistant Professor CHI Health Clinic Gastroenterology Creighton University, School of Medicine April 28, 2018 DISCLOSURES None 1 OBJECTIVES Review update
More informationGI Health Foundation DDW 2016 Functional Dyspepsia: A New Disease Model. Nicholas J. Talley MD, PhD
GI Health Foundation DDW 2016 Functional Dyspepsia: A New Disease Model Nicholas J. Talley MD, PhD Disclosure Grant / Research Support: Abbott Pharmaceuticals, Janssen, Prometheus, Pfizer, Rome Foundation
More informationDistinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2014-308114). For numbered affiliations see end of article. Correspondence to Professor
More informationJ Neurogastroenterol Motil, Vol. 17 No. 3 July, 2011 DOI: /jnm Journal of Neurogastroenterology and Motility
ㅋ JNM J Neurogastroenterol Motil, Vol. 17 No. 3 July, 2011 DOI: 10.5056/jnm.2011.17.3.279 Journal of Neurogastroenterology and Motility Original Article Functional Gastrointestinal Disorders Diagnosed
More informationGastroesophageal Reflux in Infants
Gastroesophageal Reflux in Infants Lindsey Albenberg, DO Andrew Grossman, MD The Children s Hospital of Philadelphia 2013 Resident Education Series Reviewed by Jyoti Ramakrishna, MD of the Professional
More informationPRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW
PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Dyspepsia refers to a broad range of symptoms related
More informationD yspepsia literally means bad digestion. Evaluation and treatment of dyspepsia REVIEW. M P Jones...
25 REVIEW Evaluation and treatment of dyspepsia M P Jones... Dyspepsia is a common symptom. Dyspeptic symptoms may be caused by a variety of conditions such as peptic ulcer disease, gastro-oesophageal
More informationPharmacodynamic Effects of Ghrelin Agonist Relamorelin (RM-131) in Patients with Type 1 and Type 2 Diabetes Mellitus and Delayed Gastric Emptying
Pharmacodynamic Effects of Ghrelin Agonist Relamorelin (RM-131) in Patients with Type 1 and Type 2 Diabetes Mellitus and Delayed Gastric Emptying Andrea Shin Motility Conference 2/4/15 Disclosures No conflicts
More informationDisclosures. Objectives. Gastroparesis: Are We Moving On? Gastroparesis: Clinical Overview
Gastroparesis: Are We Moving On? Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Beth Israel Deaconess Medical Center Boston, MA Disclosures Consultant Alkermes, Allergan, Forest,
More informationWhat is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?
What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori? Sequential Therapy Versus Standard Triple- Drug Therapy for Helicobacter pylori
More informationProton Pump Inhibitors (PPIs) (Sherwood Employer Group)
Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf
More informationreceptor antagonists and prokinetics in dyspepsia: a critical review
iv58 DYSPEPSIA MANAGEMENT H 2 antagonists and prokinetics in dyspepsia: a critical review P Bytzer... Drug treatment of with functional dyspepsia is controversial but H 2 antagonists have been the mainstay
More informationAlginates Extended Abstract
Alginates Extended Abstract III) Clinical practice guidelines: DeVault KR, Castell DO; American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux
More informationEmerging Treatments for IBS-C and Clinical Trial Endpoints
Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current
More informationGastroparesis and other upper GI problems DR ANDREW DAVIES
Gastroparesis and other upper GI problems DR ANDREW DAVIES Outline Gastroparesis Hiccoughs Gastroparesis Gastroparesis Definition: A syndrome of objectively delayed gastric emptying in the absence of mechanical
More informationJNM Journal of Neurogastroenterology and Motility
JNM Journal of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 20 No. 4 October, 2014 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm14010 Original Article Effects of
More informationFunctional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease
1 Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy; 2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zurich,
More informationFrom Department of Medicine, Huddinge, Division of Gastroenterology and Hepatology Karolinska Institutet, Stockholm, Sweden
From Department of Medicine, Huddinge, Division of Gastroenterology and Hepatology Karolinska Institutet, Stockholm, Sweden EVALUATIONS OF MEASUREMENT TECHNIQUES IN FUNCTIONAL DYSPEPSIA: Electrogastrography,
More information